doubleblind (observer blind), placebo-controlled, clinical-experimental study phase II in order to examine the local compatibility of Dr. Theiss Ringelblumen Salbe N by the duhring-chamber-test and in a open user trial - local compatibility test and open user trial with Dr. Theiss Ringelblumen Salbe

• Conditions: healthy subjects with normal skin conditions

• Registration Number: EUCTR2004-004466-33-DE
• Lead Sponsor: Dr. Theiss Naturwaren GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-01-09
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

written informed consent written informed data protection healthy subjects with healthy normal skin conditions age more than 18 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Volunteers who do not fulfill any of the above described criteria Volunteers who are pregnant or breast feeding Skin irritation or disease Skin dieseases or dermatological disorders Volunteeers with severe disorders Topical medication in the test areas Participation in an study in the last 4 weeks Consumption of alcohol or drugs

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified